Sirolimus
RDCRN 5403
Phase 2 small_molecule active
Quick answer
Sirolimus for Anemia, Aplastic is a Phase 2 program (small_molecule) at Ultragenyx UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx UK Limited
- Indication
- Anemia, Aplastic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active